PRESS RELEASE: Pittsburgh, PA – January 14th, 2026 – SNS Research Launches Advanced Market Intelligence Platform for visual market intelligence across pharmaceutical and healthcare markets: www.snsintel.com

Pittsburgh, PA – 14th January 2026 – SNS Research announced the official launch of the SNS Market Intelligence Platform, a next-generation solution designed to replace static reports with an interactive market intelligence portal. The platform delivers structured market and drug development pipeline data through a cloud-based dashboard featuring advanced filters, slicers, and dynamic visualizations. 

SNS Market Intelligence Platform Key Features:
• Clinical and late-stage pipeline tracking: Comprehensive tracking of assets from preclinical through pre-registration, structured to support portfolio planning and competitive intelligence.
• Market size estimates and long-term forecasts covering Therapeutic Category, Drug Delivery Route, Drug Type, Distribution Channel, Drug Class, Regional & Country markets
• Analyze the data using filters, slicers and time ranges to understand the market landscape.
• Visualizations designed to support strategic planning and investment decisions.
 
The SNS Market Intelligence Platform consolidates years of proprietary research into a single, unified interface built for biopharma strategy, business development, competitive intelligence, and investment teams. Users can interrogate market size and forecast data by geography, subsegments and at country level. Key pipeline candidates are also presented in a structured graphical format displaying molecule type, mechanism of action, and clinical stage, enabling rapid identification of white-space opportunities and strategic inflection points.
 
The launch is led by a comprehensive Dermatology In Sight module, with two focus areas: Psoriasis & Skin Cancer, and an active expansion roadmap that includes upcoming datasets on Ophthalmology (Retinal and Glaucoma), Cell & Gene Therapies, Biosimilars, and GLP-1 therapies.

Dermatology In Sight Module: Unmatched Visual Granularity
The inaugural Dermatology module provides high-resolution mapping of the global therapeutic market forecasts, segmented by mechanism of action and molecular class to deliver a precise view of competitive dynamics.

Key features include:
  • Eight Therapeutic Categories: Coverage of Psoriasis, Atopic Dermatitis, Skin Cancer, Alopecia Areata, Vitiligo, and related dermatological indications.
  • Deep-dive analytics into the therapeutic landscape, categorized by MoA and molecule type.
  • Customers can access specific market size breakdowns across:
    • Biologics: Intensive tracking of IL-23, IL-17, IL-4/13, TNF inhibitors, and IL-12/23 inhibitors, among others.
    • Small Molecules: Detailed insights into JAK inhibitors, PDE4 inhibitors, Retinoids, Calcineurin inhibitors, Corticosteroids, Vitamin D analogues, and Anti-infectives.
    • Next-Gen Innovation: Specialized coverage of Gene Therapies and other emerging therapeutic modalities.
  • 2 Focus areas: Psoriasis & Skin Cancer
  • 216 Pipeline Assets: End-to-end tracking from preclinical development through pre-registration.
  • 5 Regions and 26 Countries: Granular regional forecasts and tracking across major and emerging global markets.

As the dermatology drugs market experiences a surge in innovation, particularly within immunological pathways and precision medicine, the SNS Market Intelligence platform provides stakeholders with the data-driven clarity needed to navigate a complex competitive environment.
 
The Dermatology module is now live and available for a free trial via www.snsintel.com
   
Expansion Roadmap
Building on the Dermatology launch, SNS Intelligence will rapidly extend the platform to additional high-impact therapeutic domains, including:
  • Ophthalmology: Comprehensive intelligence across Retinal and Glaucoma markets.
  • Cell & Gene Therapies: Structured monitoring of advanced and emerging modalities.
  • Biosimilars and GLP-1 Therapies: Ongoing analysis of competitive and commercial disruption in these fast-moving segments.
This is the first step in building a broader, cross-therapy market intelligence system.
 
Availability and Free Trial
The SNS Market Intelligence Platform is available via annual subscription, with tiered access designed to support both emerging biotech companies and global pharmaceutical organizations. SNS Intelligence is offering a free limited trial to showcase the platforms capabilities. For more information or to request a trial:

Visit Us: www.snsintel.com

About SNS Research
SNS Research is global market intelligence firm focused exclusively on healthcare and life sciences. By combining deep domain expertise with rigorous data structuring and advanced visualization, SNS Research enables organizations to make informed decisions in complex and rapidly evolving markets.
 
The mission of the organization is to deliver independent, high-rigor market intelligence in an interactive visual format that enables organizations to make informed strategic decisions over time.

For enquiries, quotes, or additional information: [email protected]